Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David R Andes

Showing results (11-20 of 207) with videos related to

Pageof 21
Sort By:
Infectious Disease Clinics of North America|January 8, 2016
Antifungal Agents: Spectrum of Activity, Pharmacology, and Clinical IndicationsJeniel E Nett, David R Andes
Journal of Fungi (Basel, Switzerland)|February 8, 2020
Contributions of the Biofilm Matrix to <i>Candida</i> PathogenesisJeniel E Nett, David R Andes
Methods in Molecular Biology (Clifton, N.J.)|April 6, 2023
Analysis of Candida Antifungal Resistance Using Animal Infection ModelsDavid R Andes, Jeniel E Nett
Nature Protocols|November 4, 2016
Large-scale production and isolation of Candida biofilm extracellular matrixRobert Zarnowski, Hiram Sanchez, David R Andes
Antimicrobial Agents and Chemotherapy|February 26, 2026
Pharmacodynamic evaluation of BRII-693, a next-generation synthetic macrocyclic peptide antibiotic, in the neutropenic mouse thigh and lung infection models against gram-negative pathogensAlexander J Lepak, Yali Zhu, David R Andes
Methods in Molecular Biology (Clifton, N.J.)|February 14, 2012
Modeling of fungal biofilms using a rat central vein catheterJeniel E Nett, Karen Marchillo, David R Andes
Bioorganic & Medicinal Chemistry|November 27, 2016
Animal models in the pharmacokinetic/pharmacodynamic evaluation of antimicrobial agentsMiao Zhao, Alexander J Lepak, David R Andes
Plos Pathogens|December 14, 2018
Candida-streptococcal interactions in biofilm-associated oral diseasesHyun Koo, David R Andes, Damian J Krysan
Antimicrobial Agents and Chemotherapy|September 2, 2020
Pharmacodynamic Evaluation of MRX-8, a Novel Polymyxin, in the Neutropenic Mouse Thigh and Lung Infection Models against Gram-Negative PathogensAlexander J Lepak, Wen Wang, David R Andes
Antimicrobial Agents and Chemotherapy|December 17, 2014
Pharmacodynamic target evaluation of a novel oral glucan synthase inhibitor, SCY-078 (MK-3118), using an in vivo murine invasive candidiasis modelAlexander J Lepak, Karen Marchillo, David R Andes
Pageof 21

Showing results (11-20 of 207) with videos related to

Sort By:
Pageof 21
Infectious Disease Clinics of North America|January 8, 2016
Antifungal Agents: Spectrum of Activity, Pharmacology, and Clinical IndicationsJeniel E Nett, David R Andes
Journal of Fungi (Basel, Switzerland)|February 8, 2020
Contributions of the Biofilm Matrix to <i>Candida</i> PathogenesisJeniel E Nett, David R Andes
Methods in Molecular Biology (Clifton, N.J.)|April 6, 2023
Analysis of Candida Antifungal Resistance Using Animal Infection ModelsDavid R Andes, Jeniel E Nett
Nature Protocols|November 4, 2016
Large-scale production and isolation of Candida biofilm extracellular matrixRobert Zarnowski, Hiram Sanchez, David R Andes
Antimicrobial Agents and Chemotherapy|February 26, 2026
Pharmacodynamic evaluation of BRII-693, a next-generation synthetic macrocyclic peptide antibiotic, in the neutropenic mouse thigh and lung infection models against gram-negative pathogensAlexander J Lepak, Yali Zhu, David R Andes
Methods in Molecular Biology (Clifton, N.J.)|February 14, 2012
Modeling of fungal biofilms using a rat central vein catheterJeniel E Nett, Karen Marchillo, David R Andes
Bioorganic & Medicinal Chemistry|November 27, 2016
Animal models in the pharmacokinetic/pharmacodynamic evaluation of antimicrobial agentsMiao Zhao, Alexander J Lepak, David R Andes
Plos Pathogens|December 14, 2018
Candida-streptococcal interactions in biofilm-associated oral diseasesHyun Koo, David R Andes, Damian J Krysan
Antimicrobial Agents and Chemotherapy|September 2, 2020
Pharmacodynamic Evaluation of MRX-8, a Novel Polymyxin, in the Neutropenic Mouse Thigh and Lung Infection Models against Gram-Negative PathogensAlexander J Lepak, Wen Wang, David R Andes
Antimicrobial Agents and Chemotherapy|December 17, 2014
Pharmacodynamic target evaluation of a novel oral glucan synthase inhibitor, SCY-078 (MK-3118), using an in vivo murine invasive candidiasis modelAlexander J Lepak, Karen Marchillo, David R Andes
Pageof 21